{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:23:33Z","timestamp":1777447413823,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Connective Tissue Diseases Research Center of Tabriz University of Medical Sciences"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.imlet.2018.10.012","type":"journal-article","created":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T13:35:14Z","timestamp":1540301714000},"page":"55-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Determination of mir-155 and mir-146a expression rates and its association with expression level of TNF-\u03b1 and CTLA4 genes in patients with Behcet\u2019s disease"],"prefix":"10.1016","volume":"204","author":[{"given":"Sousan","family":"Kolahi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad-Jahed","family":"Farajzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahriar","family":"Alipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Abhari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jafar","family":"Farhadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neda","family":"Bahavarnia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aida","family":"Malek Mahdavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Khabbazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebrahim","family":"Sakhinia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2018.10.012_bib0005","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jaut.2009.02.011","article-title":"Behcet\u2019s disease-a contemporary review","volume":"32","author":"Mendes","year":"2009","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.imlet.2018.10.012_bib0010","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.autrev.2009.10.005","article-title":"Etiopathogenesis of Behcet\u2019s disease","volume":"9","author":"Mendoza-Pinto","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.imlet.2018.10.012_bib0015","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/1756-185X.12153","article-title":"The status of serum vitamin D in patients with active Behcet\u2019s disease compared with controls","volume":"17","author":"Khabbazi","year":"2014","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.imlet.2018.10.012_bib0020","first-page":"1","article-title":"Cigarette smoking and risk of Behcet\u2019s disease: a propensity score matching analysis","volume":"26","author":"Malek Mahdavi","year":"2018","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.imlet.2018.10.012_bib0025","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/art.24642","article-title":"HLA-B51\/B5 and the risk of Behcet\u2019s disease: a systematic review and meta-analysis of case-control genetic association studies","volume":"61","author":"de Menthon","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2018.10.012_bib0030","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.biopha.2017.04.106","article-title":"Epigenetic alterations in chronic disease focusing on Behcet\u2019s disease: review","volume":"91","author":"Alipour","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.imlet.2018.10.012_bib0035","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.autrev.2011.11.026","article-title":"New insights into the pathogenesis of Behcet\u2019s disease","volume":"11","author":"Pineton de Chambrun","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.imlet.2018.10.012_bib0040","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2230.2004.01684.x","article-title":"Serum interleukin 18 and tumor necrosis factor-alpha levels are increased in Behcet\u2019s disease","volume":"30","author":"Oztas","year":"2005","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.imlet.2018.10.012_bib0045","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/1521-4141(200202)32:2<366::AID-IMMU366>3.0.CO;2-5","article-title":"CTLA-4 regulates cell cycle progression during a primary immune response","volume":"32","author":"Greenwald","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imlet.2018.10.012_bib0050","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00439-004-1244-1","article-title":"CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis","volume":"116","author":"Lee","year":"2005","journal-title":"Hum. Genet."},{"key":"10.1016\/j.imlet.2018.10.012_bib0055","first-page":"S100","article-title":"Cytotoxic T lymphocyte antigen-4 (CTLA-4) polymorphism in patients with Behcet\u2019s disease","volume":"28","author":"Duzgun","year":"2010","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.imlet.2018.10.012_bib0060","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1136\/bjo.2008.156919","article-title":"No association of CTLA-4 polymorphisms with susceptibility to Behcet disease","volume":"93","author":"Du","year":"2009","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.imlet.2018.10.012_bib0065","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1399-0039.2008.01186.x","article-title":"CTLA-4 +49A\/G polymorphism is associated with Behcet\u2019s disease in a Tunisian population","volume":"73","author":"Dhifallah","year":"2009","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.imlet.2018.10.012_bib0070","first-page":"S132","article-title":"CTLA-4 gene variants are not associated with Behcet\u2019s disease or its clinical manifestations","volume":"26","author":"Touma","year":"2008","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.imlet.2018.10.012_bib0075","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1399-0039.2008.01062.x","article-title":"CTLA-4 polymorphisms are not associated with ocular inflammatory disease","volume":"72","author":"Bye","year":"2008","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.imlet.2018.10.012_bib0080","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1744-313X.2007.00655.x","article-title":"Analysis of CD28 and CTLA-4 gene polymorphisms in Turkish patients with Behcet\u2019s disease","volume":"34","author":"Gunesacar","year":"2007","journal-title":"Int. J. Immunogenet."},{"key":"10.1016\/j.imlet.2018.10.012_bib0085","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1365-2230.2005.01846.x","article-title":"CTLA-4 gene 49A\/G polymorphism in Turkish patients with Behcet\u2019s disease","volume":"30","author":"Sallakci","year":"2005","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.imlet.2018.10.012_bib0090","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.imlet.2018.10.012_bib0095","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.gene.2013.03.073","article-title":"Association between miR-146a rs2910164 polymorphism and autoimmune diseases susceptibility: a meta-analysis","volume":"521","author":"Chen","year":"2013","journal-title":"Gene."},{"key":"10.1016\/j.imlet.2018.10.012_bib0100","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1084\/jem.20101823","article-title":"miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice","volume":"208","author":"Boldin","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2018.10.012_bib0105","first-page":"22","article-title":"miR-146 and miR-155: two key modulators of immune response and tumor development","volume":"3","author":"Testa","year":"2017","journal-title":"Noncoding RNA"},{"key":"10.1016\/j.imlet.2018.10.012_bib0110","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jaci.2010.05.045","article-title":"MiR-155 is overexpressed in patients with atopic dermatitis and modulates T-cell proliferative responses by targeting cytotoxic T lymphocyte\u2013associated antigen 4","volume":"126","author":"Sonkoly","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.imlet.2018.10.012_bib0115","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1177\/0961203314534512","article-title":"Association of miR-146a polymorphisms with systemic lupus erythematosus: a meta-analysis","volume":"23","author":"Ji","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.imlet.2018.10.012_bib0120","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1111\/jcmm.12359","article-title":"A single-nucleotide polymorphism of miR-146a and psoriasis: an association and functional study","volume":"18","author":"Zhang","year":"2014","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.imlet.2018.10.012_bib0125","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.3899\/jrheum.100308","article-title":"Serum and urinary cell-free MiR-146a and MiR-155 in patients with systemic lupus erythematosus","volume":"37","author":"Wang","year":"2010","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.imlet.2018.10.012_bib0130","doi-asserted-by":"crossref","first-page":"11193","DOI":"10.1073\/pnas.1019536108","article-title":"MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis","volume":"108","author":"Kurowska-Stolarska","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imlet.2018.10.012_bib0135","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00439-013-1346-8","article-title":"A functional variant of pre-miRNA-196a2 confers risk for Behcet\u2019s disease but not for Vogt-Koyanagi-Harada syndrome or AAU in ankylosing spondylitis","volume":"132","author":"Qi","year":"2013","journal-title":"Hum. Genet."},{"key":"10.1016\/j.imlet.2018.10.012_bib0140","doi-asserted-by":"crossref","first-page":"5665","DOI":"10.1167\/iovs.12-9832","article-title":"Decreased microRNA-155 expression in ocular Behcet\u2019s disease but not in Vogt Koyanagi Harada syndrome","volume":"53","author":"Zhou","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.imlet.2018.10.012_bib0145","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s10072-015-2419-3","article-title":"Increased complexin-1 and decreased miR-185 expression levels in Behcet\u2019s disease with and without neurological involvement","volume":"37","author":"U\u011furel","year":"2016","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.imlet.2018.10.012_bib0150","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00109-014-1159-9","article-title":"Predisposition to Beh\u00e7et\u2019s disease and VKH syndrome by genetic variants of miR-182","volume":"92","author":"Yu","year":"2014","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.imlet.2018.10.012_bib0155","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00439-013-1346-8","article-title":"A functional variant of pre-miRNA-196a2 confers risk for Behcet\u2019s disease but not for Vogt-Koyanagi-Harada syndrome or AAU in ankylosing spondylitis","volume":"132","author":"Qi","year":"2013","journal-title":"Hum. Genet."},{"key":"10.1016\/j.imlet.2018.10.012_bib0160","first-page":"S14","article-title":"Revision of the international criteria for Behcet\u2019s disease (ICBD)","volume":"24","author":"International Team for the Revision of the International Criteria for Behcet\u2019s Disease","year":"2006","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.imlet.2018.10.012_bib0165","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/rheumatology\/38.8.728","article-title":"Behcet\u2019s disease: evaluation of a new instrument to measure clinical activity","volume":"38","author":"Bhakta","year":"1999","journal-title":"Rheumatology"},{"key":"10.1016\/j.imlet.2018.10.012_bib0170","first-page":"134","article-title":"Iran Behcet\u2019s disease dynamic activity measure. Abstracts of the XIIth European congress of rheumatology","volume":"32","author":"Davatchi","year":"1991","journal-title":"Hungarian Rheumatol."},{"key":"10.1016\/j.imlet.2018.10.012_bib0175","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3109\/s10165-009-0191-z","article-title":"Comparison of existing disease activity indices in the follow-up of patients with Behcet\u2019s disease","volume":"19","author":"Shahram","year":"2009","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.imlet.2018.10.012_bib0180","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1093\/molbev\/msn165","article-title":"c-Myb is an evolutionary conserved miR-150 target and miR-150\/c-Myb interaction is important for embryonic development","volume":"25","author":"Lin","year":"2008","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.imlet.2018.10.012_bib0185","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cell.2007.07.021","article-title":"MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb","volume":"131","author":"Xiao","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.imlet.2018.10.012_bib0190","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/ni.1798","article-title":"MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis","volume":"10","author":"Du","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2018.10.012_bib0195","first-page":"S56","article-title":"MicroRNA-155 regulates the Th17 immune response by targeting Ets-1 in Behcet\u2019s disease","volume":"34","author":"Na","year":"2016","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.imlet.2018.10.012_bib0200","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.cell.2010.08.012","article-title":"Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses","volume":"142","author":"Lu","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.imlet.2018.10.012_bib0205","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/art.24436","article-title":"MicroRNA146a contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins","volume":"60","author":"Tang","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2018.10.012_bib0210","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/annrheumdis-2012-201627","article-title":"MicroRNA-146a and Ets-1 gene polymorphisms in ocular Beh\u00e7et\u2019s disease and Vogt\u2013Koyanagi\u2013Harada syndrome","volume":"73","author":"Zhou","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"July (10)","key":"10.1016\/j.imlet.2018.10.012_bib0215","article-title":"MicroRNA-146a expression and microRNA-146a rs2910164 polymorphism in Behcet\u2019s disease patients","author":"Ibrahim","year":"2018","journal-title":"Clin. Rheumatol."},{"issue":"6","key":"10.1016\/j.imlet.2018.10.012_bib0220","doi-asserted-by":"crossref","first-page":"20057","DOI":"10.1038\/srep20057","article-title":"miR-23a, miR-146a and miR-301a confer predisposition to Vogt-Koyanagi-Harada syndrome but not to Behcet\u2019s disease","volume":"28","author":"Hou","year":"2016","journal-title":"Sci. Rep."},{"issue":"August (5)","key":"10.1016\/j.imlet.2018.10.012_bib0225","article-title":"The MicroRNA-326: autoimmune diseases, diagnostic biomarker, and therapeutic target","author":"Jadideslam","year":"2018","journal-title":"J. Cell. Physiol."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247818303808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247818303808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:35:06Z","timestamp":1759044906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247818303808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":45,"alternative-id":["S0165247818303808"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2018.10.012","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determination of mir-155 and mir-146a expression rates and its association with expression level of TNF-\u03b1 and CTLA4 genes in patients with Behcet\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2018.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}